# Cinacalcet for Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia (Hypophosphatemic Rickets)

> **NCT01748812** · PHASE1 · TERMINATED · sponsor: **National Institute of Dental and Craniofacial Research (NIDCR)** · enrollment: 1 (actual)

## Conditions studied

- Osteomalacia

## Interventions

- **DRUG:** Osteomalacia

## Key facts

- **NCT ID:** NCT01748812
- **Lead sponsor:** National Institute of Dental and Craniofacial Research (NIDCR)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-11-16
- **Primary completion:** 2016-12-31
- **Final completion:** 2016-12-31
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2018-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01748812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01748812, "Cinacalcet for Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia (Hypophosphatemic Rickets)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01748812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*